Oren Gilad Insider Profile

4 Followers
Oren Gilad, President & CEO, Director at Aprea Therapeutics, holds 335.19K shares in Aprea Therapeutics (Ticker: APRE). Most recently, Oren Gilad Bought $500 shares of Aprea Therapeutics on Oct 24, 2024 for an estimated value of 1.96K.
tipranks
Oren Gilad

Oren Gilad
Aprea Therapeutics (APRE)
President & CEO, Director

Ranked #38,254 out of 99,218 Corporate Insiders

Profitable Transactions

75%
3 out of 4 Profitable Transactions

Average Return

+3.70%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$1M
100.00%
A breakdown of Oren Gilad's holdings

Insider Roles

Aprea Therapeutics
(APRE)
President & CEO, Director
Roles that Oren Gilad holds in companies

Most Profitable Insider Trade

Stock:
Aprea Therapeutics
(APRE)
Rating:Informative Buy
Date:Oct 15, 2024 - Today
Return:+28.50%
The most profitable trade made by Oren Gilad

Oren Gilad's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Aprea Therapeutics
Oct 24, 2024
President & CEO, Director
Informative Buy
1.96K
$1.19M
Success Rate for
APRE
3 out of 4 profitable transactions on
APRE
75%
Average Return for
APRE
Average return per transaction on
APRE
+3.72%
Date
Transaction
Amount
No. of Shares
Price per Share
Profit
Link to Report
Aug 01, 2022
Uninformative Buy
$0.00
-
$0.00
Mar 13, 2023
Uninformative Buy
$0.00
-
$0.00
Mar 14, 2024
Informative Buy
$14.58K
-
$7.29
-26.10%
Mar 28, 2024
Uninformative Buy
$0.00
-
$0.00
Oct 15, 2024
Informative Buy
$2.97K
-
$2.58
+28.50%
List of latest transactions for each holding click on a transaction to see Oren Gilad's performance on stock

Oren Gilad insider profile FAQ

What is the percentage of profitable transactions made by Oren Gilad?
The percentage of profitable transactions made by Oren Gilad is 75%.
    What is the average return per transaction made by Oren Gilad?
    The average return per transaction made by Oren Gilad is 3.70%.
      What stocks does Oren Gilad hold?
      Oren Gilad holds: APRE stocks.
        What was Oren Gilad’s latest transaction?
        Oren Gilad latest transaction was an Informative Buy of $1.96K.
          What was Oren Gilad's most profitable transaction?
          Oren Gilad’s most profitable transaction was an Informative Buy of APRE stock on October 15, 2024. The return on the trade was 28.50%.
            What is Oren Gilad's role in Aprea Therapeutics?
            Oren Gilad's role in Aprea Therapeutics is President & CEO, Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.